 | Up a level |
Menard, C., Navarro-Domenech, I., Liu, Z., Joseph, L., Barkati, M., Berlin, A., Delouya, G., Taussky, D., Beauchemin, M.-C., Nicolas, B., Kadoury, S., Rink, A., Raman, S., Sundaramurthy, A., Weersink, R., Beliveau-Nadeau, D., Helou, J., & Chun, P. (2022). Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Frontiers in Oncology, 12, 2 pages. External link
Menard, C., Navarro-Domenech, I., Liu, Z., Joseph, L., Barkati, M., Berlin, A., Delouya, G., Taussky, D., Beauchemin, M.-C., Nicolas, B., Kadoury, S., Rink, A., Raman, S., Sundaramurthy, A., Weersink, R., Beliveau-Nadeau, D., Helou, J., & Chun, P. (2022). MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Frontiers in Oncology, 12, 971344 (9 pages). External link
Navarro, I., Joseph, L., Liu, Z., Taussky, D., Delouya, G., Barkati, M., Beauchemin, M.-C., Niazi, T., Berlin, A., Helou, J., Raman, S., Beliveau-Nadeau, D., Kadoury, S., Rink, A., Chung, P., & Menard, C. (2021, May). Outcomes in focal vs. dose-painted salvage HDR brachytherapy for locally recurrent prostate cancer [Abstract]. World Congress of Brachytherapy. Published in Radiotherapy and Oncology, 158. External link
